Keith Graham (@graham_kan) 's Twitter Profile
Keith Graham

@graham_kan

Brit in MedChem @ Boehringer-Ingelheim. Tweets = personal opinion

ID: 1069215844897615873

calendar_today02-12-2018 13:04:57

16 Tweet

152 Followers

288 Following

Duy Nguyen (@duynguyen_bayer) 's Twitter Profile Photo

Happy to announce our paper on the potent and highly selective in vitro probe BAY-885 for the kinase ERK5 has been just accepted pubs.acs.org/doi/abs/10.102…

Christian Stegmann (@cmstegmann) 's Twitter Profile Photo

RAS genes are major oncogenes but have generally been considered undruggable. Check out our latest paper: A dual approach (FBS+HTS) supported by x-ray and biophysics generated selective nM compounds for SOS1 (activator of RAS). lnkd.in/eTcZGPt

Ingo Hartung (@hartungingo) 's Twitter Profile Photo

Targeting Ras, the nemesis of cancer drug discovery. A new paper by my colleagues Bayer | Pharmaceuticals is showcasing the beauty of lead design: Hybridizing a hit from a fragment screen with a HTS lead series gives the potent probe BAY-293: @EvotecAG PNASNews pnas.org/content/early/…

Targeting Ras, the nemesis of cancer drug discovery. A new paper by my colleagues <a href="/BayerPharma/">Bayer | Pharmaceuticals</a> is showcasing the beauty of lead design: Hybridizing a hit from a fragment screen with a HTS lead series gives the potent probe BAY-293: @EvotecAG <a href="/PNASNews/">PNASNews</a> pnas.org/content/early/…
Keith Graham (@graham_kan) 's Twitter Profile Photo

Proud to have been part of a great team effort! Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS–SOS1 interaction pnas.org/content/early/…

American Chemical Society (@amerchemsociety) 's Twitter Profile Photo

After careful consideration for the safety of our members, the local community and our staff, ACS has decided to terminate the ACS Spring 2020 National Meeting in Philadelphia (#ACSPhilly). Please visit the meeting web page for complete details: ow.ly/FrEr50yH15p

Julien Lefranc (@lefrancju) 's Twitter Profile Photo

First disclosure !!!!! Do you want to learn more about our AhR antagonist currently in Phase 1 ? Check Norbert’s talk next week at the virtual EFMC Program : efmc-ismc-virtual.org/speakers #NuvisanICB EFMC Bayer | Pharmaceuticals #immunooncology

First disclosure !!!!! Do you want to learn more about our AhR antagonist currently in Phase 1 ? Check Norbert’s talk next week at the virtual EFMC            Program : efmc-ismc-virtual.org/speakers #NuvisanICB <a href="/EuroMedChem/">EFMC</a>  <a href="/BayerPharma/">Bayer | Pharmaceuticals</a> #immunooncology
Keith Graham (@graham_kan) 's Twitter Profile Photo

After 17 years on campus, today is my last day - very strange feeling!! Will miss a lot of friends and colleagues! Would like to thank Nuvisan ICB, Bayer and Schering for believing in me!! New adventure starts Jan 2021!

After 17 years on campus, today is my last day - very strange feeling!! Will miss a lot of friends and colleagues! Would like to thank Nuvisan ICB, Bayer and Schering for believing in me!! New adventure starts Jan 2021!
Keith Graham (@graham_kan) 's Twitter Profile Photo

First day of my new adventure at Boehringer-Ingelheim completed! Strange to start a new job remotely, was interesting! Looking forward to learning loads and meeting new colleagues!

Julien Lefranc (@lefrancju) 's Twitter Profile Photo

Our Next #MedChemCASES is coming !! and it s a joint event with the EFMC Young Scientists Network . The webinar will be followed by a round table discussing the life as foreign scientist in Germany !! Register here : us06web.zoom.us/webinar/regist… #webinar #medchem #research

Our Next #MedChemCASES is coming !! and it s a joint event with the <a href="/YoungSciNet/">EFMC Young Scientists Network</a> . The webinar will be followed by a round table discussing the life as foreign scientist in Germany !! Register here : us06web.zoom.us/webinar/regist…
 #webinar #medchem #research